Macrophages: Good, Bad。
因热爱而深耕，因专一而长久，
因纯粹而真诚，因严谨而可靠。
品牌故事
2018年 Target Technology首次被期刊Cell引用，客户单位清华大学。
靶点科技（Target Technology）成立于2016年。Target Technology，凭借由海归博士与国内顶尖科研院校人才组成的专业技术团队，深耕单核巨噬细胞系统研究领域，以靶向技术为核心，为全球科研工作者提供精准、可靠的科研解决方案。成立伊始，联合荷兰Nico Van Rooijen免疫学家研发的产品：氯膦酸钠脂质体与对照脂质体巨噬细胞清除套装（货号C283539），因在2018年《Cell》发表的经典论文《The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery》中被成功应用，成为科研领域备受瞩目的明星产品。
唐朝诗人贾岛《剑客》：十年磨一剑，霜刃未曾试。今日把示君，谁有不平事？有。产品同化，价格低卷，分装贴牌等乱像丛生。自成立十年以来，Target Technology以品质为基石，以专业传口碑，积累了众多终端用户，同时，作为先驱者，Target Technology提供脂质体试剂贴牌代工服务（OEM）给同行数年。时势造英雄，机遇立靶点。Biotarget®品牌从幕后走向台前。
我们深耕理论、笃行实验、精益求精。以单核 / 巨噬细胞清除技术为研发起点，聚焦细分领域稳步发展。团队专注利基空间（Niche），从巨噬细胞（Macrophages）的生物学特性中汲取灵感：这类细胞贯穿机体全生命周期、分布于全身各处，其表型，功能与命运始终受局部微环境（Niche）调控。
秉持Hit what we targeted的Biotarget®产品研发初心，不贪求广度，只雕琢精度，Target Technology矢志助力每一位研究者 hit your target®。
Cell-Del®Clodronate Liposome。该试剂可特异性耗竭巨噬细胞，性能优异，现已广泛应用于各类免疫学研究。
巨噬细胞在免疫系统中功能复杂，常被称作 “双刃剑”。其作用兼具保护与致病两面性，具体表现取决于细胞活化状态及所处微环境。
巨噬细胞遍布人体所有器官。在脊椎动物体内，自发育早期开始，几乎各类组织中均存在巨噬细胞，并伴随机体终生。靶向调控巨噬细胞，已成为极具潜力的疾病治疗方向。
Biotarget®—— 值得信赖的巨噬细胞清除专业品牌。深耕巨噬细胞研究领域，始终与科研工作者携手同行、全程相伴。
Cell-Del®Clodronate Liposome，an efficient reagent for the selective depletion of macrophages has been developed and successfully applied in many immunological studies.
Macrophages are often described as "a double-edged sword" due to their complex roles in the immune system. They can act as both protective and pathogenic cells, depending on their activation state and the context in which they are found.
Macrophages are the only cells present in every organ of our body. In vertebrates, macrophages are found in nearly every tissue from the early stages of development and persist throughout the lifetime of the organism. Targeting macrophages has emerged as a promising therapeutic strategy in some contexts.
A trusted macrophages depletion brand: biotarget®, serve as a beautiful reminder that there are people in your macrophage research who will stand by you through thick and thin.
Our value
